Tiziana Life Sciences: Putting research first
AIM-listed Tiziana Life Sciences has a new head: The clinical stage biotechnology company developing targeted drugs for cancer and autoimmune diseases appointed Kunwar Shailubhai Chief Executive Officer and Chief Scientific Officer.
Shailubhai was previously a Non-Executive Director at Tiziana. His appointment follows many years working at Synergy Pharmaceuticals Inc., which he co-founded and where he served as Chief Scientific Officer since 2008.
Prior to joining Tiziana Life Sciences and Synergy Life Sciences, he worked at Callisto Pharmaceuticals, Monsanto and as a senior staff fellow at the National Institutes of Health (NIH).